Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr 20;22(4):546-50.
doi: 10.1021/bc100579d. Epub 2011 Mar 23.

Supramolecular complexing of membane Siglec CD22 mediated by a polyvalent heterobifunctional ligand that templates on IgM

Affiliations

Supramolecular complexing of membane Siglec CD22 mediated by a polyvalent heterobifunctional ligand that templates on IgM

Lina Cui et al. Bioconjug Chem. .

Abstract

We report the synthesis and in vitro evaluation of a multivalent homing device, a polymer which contains preordered pendant groups with dual specificity, a trisaccharide moiety, which is specific for the siglec CD22, and an antibody specific hapten, nitrophenol. The device efficiently attracts antihapten IgM to the surface of human lymphoma B cells as well as to CD22-conjugated magnetic beads by mediating the formation of a ternary complex on the surface of the target.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Assembly of immune complex of IgM and CD22 mediated by a polyvalent heterobifunctional ligand.
Figure 2
Figure 2
Structures of polyvalent heterobifunctional ligand 1, its unimeric control ligand 2, and its polyvalent LacNAc control ligand 3.
Figure 3
Figure 3
Binding of anti-NP IgM to CD22 on BJAB cells. Formation of IgM-CD22 complex was assessed by incubating BJAB cells with ligands at various concentrations and FITC labeled anti-NP IgM at 10 μg/mL, staining with FITC-anti-IgM, and measuring cell flurorescence by flow cytometry. (a) Histograms of cells treated with polyvalent ligand 1 (left) and unimeric ligand 2 (right). (b) Comparison of mean channel fluorescence (MCF) of cell samples treated with 1 and 2 at various concentrations.
Figure 4
Figure 4
Avidity of complex formation mediated by ligand 1 and 3 was analyzed by titrating ligands in the presence of CD22 immobilized on magnetic beads and FITC labeled anti-NP IgM (5 μg/mL), and measuring bead fluorescence by flow cytometry. Mean channel fluorescence (MCF) is plotted against ligand concentration.
Scheme 1
Scheme 1
Synthesis of polyvalent heterobifunctional ligand 1.

References

    1. Carlson CB, Mowery P, Owen RM, Dykhuizen EC, Kiessling LL. Selective tumor cell targeting using low-affinity, multivalent interactions. ACS Chem Biol. 2007;2:119–127. - PubMed
    1. Owen RM, Carlson CB, Xu JW, Mowery P, Fasella E, Kiessling LL. Bifunctional ligands that target cells displaying the alphavbeta3 integrin. ChemBioChem. 2007;8:68–82. - PubMed
    1. Murelli RP, Zhang AX, Michel J, Jorgensen WL, Spiegel DA. Chemical control over immune recognition: a class of antibody-recruiting small molecules that target prostate cancer. J Amer Chem Soc. 2009;131:17090–17092. - PMC - PubMed
    1. Popkov M, Gonzalez B, Sinha SC, Barbas CF. Instant immunity through chemically programmable vaccination and covalent self-assembly. Proc Natl Acad Sci U S A. 2009;106:4378–4383. - PMC - PubMed
    1. Lu YJ, Sega E, Leamon CP, Low PS. Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential. Adv Drug Deliv Rev. 2004;56:1161–1176. - PubMed

Publication types

MeSH terms